.... the DEP .... the jewel in the crown (supposedly) ... the one nobody wants 'apparently' - well not at the price Starpharma want to license it for or they would have signed a license agreement by now ? ..... you know the one that they have been in confidential commercial discussions with several potential partners with for years and even after subsequent multiple phase 2 trial data releases there is still no DEP license deal ? Why is that if the science is supposedly so good like many on here claim ?
I think the best LT suffering shareholders can now hope for is an opportunistic takeover by one of the remaining players that have shown a meek interest in our ADCs .... I say meek because none of them paid Starpharma an upfront fee when they signed these research agreements (partnerships if you believe the rhetoric coming out of the company) .... and people wonder why even the ASX themselves alleged the company was ramping in multiple ASX announcements on 12 Jan 2023 and we know they saw more information than us retail punters when they made that accusation ?
ALL the Substantial Holders left at huge losses for a reason - just sayin'
SPL Price at posting:
12.0¢ Sentiment: Hold Disclosure: Held
..... you know the one that they have been in confidential commercial discussions with several potential partners with for years and even after subsequent multiple phase 2 trial data releases there is still no DEP license deal ? Why is that if the science is supposedly so good like many on here claim ?
(20min delay)